QCM
BBNX

Quantinno Capital Management’s Beta Bionics BBNX Stock Holding History

Quantinno Capital Management’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$680K Buy
67,879
+35,996
+113% +$532K ﹤0.01% 2482
2025
Q4 		$971K Buy
31,883
+5,273
+20% +$141K ﹤0.01% 1818
2025
Q3 		$529K Buy
26,610
+6,840
+35% +$120K ﹤0.01% 1970
2025
Q2 		$288K Buy
+19,770
New +$280K ﹤0.01% 2054

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Quantinno Capital Management's BBNX Position: Q1 2026 in Review

Quantinno Capital Management increased its Beta Bionics (BBNX) stake by 113% in Q1 2026, buying an estimated $532K and bringing the position to 67,879 shares worth $680K. The position accounts for ﹤0.01% of the portfolio, ranked #2482.

Quantinno Capital Management first reported a position in BBNX in Q2 2025 and has held it in 4 quarters since. The position peaked at $971K in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Quantinno Capital Management held 67,879 shares of Beta Bionics worth $680K as of Q1 2026.
  • Quantinno Capital Management bought 35,996 Beta Bionics shares in Q1 2026, an estimated $532K.
  • Beta Bionics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #2482 holding.
  • Quantinno Capital Management first reported a position in Beta Bionics in Q2 2025 and has held it in 4 quarters since.
  • Quantinno Capital Management's Beta Bionics position peaked at $971K in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.